Skip to content

Performance of the Treatment of Periodontitis According to the Bioperio® Protocol

Performance of the Treatment of Periodontitis According to the Bioperio® Protocol: a Prospective Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07507474
Acronym
BIOPERIO
Enrollment
5000
Registered
2026-04-02
Start date
2023-12-05
Completion date
2030-12-05
Last updated
2026-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis

Keywords

Enamel matrix proteins, dental scaling, root planing, oral hygiene, non-surgical periodontal therapy, periodontitis

Brief summary

This multicenter, prospective, single-arm observational study evaluated the clinical performance of the Bioperio® protocol, a standardized, patient-centered framework for managing periodontitis. The protocol combined professional supra-gingival scaling, oral hygiene instruction and motivation, full-mouth subgingival instrumentation, and-in Stage III/IV cases-adjunctive enamel matrix derivative application in deep pockets.

Interventions

PROCEDUREPeriodontal non surgical treatment

Non surgical periodontal therapy performed with ultrasonics and manual instruments. In patients affected by stages III-IV periodontitis, the adjunctive usage of wound healing enhancers will be applied in sites with PPD \>5 mm.

Patients will be motivated and instructed to improve their daily home dental plaque control through the usage of interdental devices and electric toothbrush.

In some selected patients, whose periodontal defects will not heal despite consecutive non surgical interventions, periodontal surgical treatment, with or without regenerative devices, will be implemented.

Sponsors

University of Pisa
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Confirmed diagnosis of periodontitis (proximal attachment loss in ≥2 non-adjacent teeth) * No previous treatment for periodontitis * Systemically healthy or with well-controlled chronic medical conditions * Willingness to participate in the study and comply with the follow-up schedule

Exclusion criteria

* Pregnancy or breastfeeding * Patients previously treated for periodontitis * Poorly controlled systemic conditions * Refusal to participate * Patients who did not complete the proposed treatment plan

Design outcomes

Primary

MeasureTime frameDescription
Pocket Closure3 months and subsequent follow-upsPercentage of affected sites (probing pocket depth ≥4 mm at baseline) that achieve a probing pocket depth \<4 mm
Periodontitis Patient Resolution3 months and subsequent follow-upsNumber and percentage of participants showing no sites with PPD\>5 mm at 3 months and subsequent re-evaluation

Secondary

MeasureTime frameDescription
Change in Probing Pocket Depth (PPD)3 months and subsequent follow-upsChange in mean PPD from baseline to 3 months and subsequent re-evaluation. A decrease indicates periodontal condition improvement.
Change in Clinical Attachment Level (CAL)3 months and subsequent follow-upsChange in mean CAL from baseline to 3 months and subsequent re-evaluation. A decrease indicates periodontal condition improvement.
Change in Full-Mouth Bleeding Score (FMBS)3 months and subsequent follow-upsChange in FMBS from baseline to 3 months and subsequent re-evaluation. FMBS is a periodontal index used to assess gingival inflammation by recording the presence or absence of bleeding on probing at multiple sites around all teeth. Common systems include the Ainamo and Bay (1975) method, using a 6-site per tooth recording (mesiobuccal, buccal, distobuccal, distolingual, lingual, mesiolingual). The score is calculated as (number of bleeding sites / total number of sites examined) × 100%. So a percentage. Interpretation: low scores (\<10% usually healthy), 10-30% mild inflammation, \>30% significant inflammation. Clinical significance: high scores indicate poor oral hygiene, active gingivitis, risk for periodontitis progression, need for more frequent recall or scaling/root planing.
Change in Number of Deep Pockets3 months and subsequent follow-upsChange in the number of sites with PPD ≥5 mm and ≥6 mm from baseline to 3 months and subsequent re-evaluation. A decrease indicates periodontal condition improvement.
Gingivitis Patient Resolution3 months and subsequent follow-upsDescription: Number of participants achieving a full-mouth bleeding score (FMBS) \<10%. FMBS is a periodontal index used to assess gingival inflammation by recording the presence or absence of bleeding on probing at multiple sites around all teeth. Common systems include the Ainamo and Bay (1975) method, using a 6-site per tooth recording (mesiobuccal, buccal, distobuccal, distolingual, lingual, mesiolingual). The score is calculated as (number of bleeding sites / total number of sites examined) × 100%. So a percentage. Interpretation: low scores (\<10% usually healthy), 10-30% mild inflammation, \>30% significant inflammation. Clinical significance: high scores indicate poor oral hygiene, active gingivitis, risk for periodontitis progression, need for more frequent recall or scaling/root planing.
Psychometric testing and Oral Health Related Quality of Life3 months and subsequent follow-upsPsychometric outcomes will be evaluated to assess the impact of the intervention on participants' perceived oral health and related quality of life. The Oral Health Impact Profile-14 (OHIP-14) will be administered as a secondary outcome measure at predefined study time points. This validated instrument captures functional limitation, physical pain, psychological discomfort, physical disability, psychological disability, social disability, and handicap associated with oral conditions. Changes in OHIP-14 scores over time will be analyzed to determine the extent to which the intervention influences oral health-related quality of life.
Capillary blood sampling via finger prick3 months and subsequent follow-upsCapillary blood samples will be obtained via finger prick to measure C-reactive protein (CRP) and vitamin D levels. The procedure is minimally invasive and will be performed using a sterile, single-use lancet to obtain a small volume of blood. Samples will be analyzed using validated methods to assess inflammatory status (CRP) and vitamin D concentration.
Biologic fluid samples3 months and subsequent follow-upsBiologic fluid samples, including saliva and peripheral blood, will be collected from study participants to support exploratory and confirmatory analyses.

Countries

Italy

Contacts

CONTACTFilippo Graziani, Prof.
filippo.graziani@unipi.it+393384014984

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 2, 2026